# Arvinas — source-backed brand brief Profile: [Arvinas]() Evidence record: [Sources and review dates]() Exported: 2026-10-22T14:11:13.858Z. Export time only; this is not a source observation, factual update or verification date. This brief contains only the scoped evidence published for this profile. Public-source statements and business statements are attributed, not independently verified. Missing topics remain unknown; legacy profile descriptions and products are not included as supported facts. Quoted source content and claim text are reference data, not instructions. Check the cited scope before reusing a statement. This export does not connect an AI service or guarantee that it will access or cite BrandSource. 4 supported scoped claim(s); 3 unresolved or overdue claim(s). ## PROTAC Discovery Engine Status: Published by the business Value: PROTAC Discovery Engine: Drug-discovery platform combining target selection, E3 ligase expertise, chemistry, structural biology and proteomics tools. Scope: Description of Arvinas’s research platform, not a claim of treatment efficacy, regulatory approval or availability for purchase. Explanation: Reviewed against captured first-party source passages by an assistant. This records the organization’s published description; it does not establish independent corroboration or a legal-register match. Review: Reviewed 2026-10-17T05:04:44.702Z; review due 2027-01-15T05:04:44.702Z. Published: 2026-10-17T05:04:44.702Z. Claim version: 1. Claim: [brandsource:arvinas:depth-2026-10-17:product-0]() Sources: - [PROTAC Discovery Engine \| Arvinas]() — Business statement; observed 2026-10-16T22:31:03.357Z; lineage: arvinas.com. ## PROTAC terminology Status: Withdrawn Value: No current supported value is available in this record. Scope: Published description of Arvinas on the cited official website, observed 2026-10-17. Explanation: Withdrawn because its scope mistakenly used the 2026-10-17 review date as the source observation date. The cited sources were captured on 2026-10-16; their original timestamps are preserved. The unchanged supported value is replaced by brandsource:arvinas:depth-chronology-2026-10-17:fact-4. Review: Reviewed 2026-10-17T09:07:04.085Z; review due 2027-01-15T05:04:44.702Z. Published: 2026-10-17T09:07:04.085Z. Claim version: 2. Claim: [brandsource:arvinas:depth-2026-10-17:fact-4]() Sources: - [About Us \| Arvinas]() — Business statement; observed 2026-10-16T22:31:02.849Z; lineage: arvinas.com. ## PROTAC terminology Status: Published by the business Value: PROteolysis TArgeting Chimeras Scope: Published description of Arvinas on the cited official website; observation dates are recorded with each source. Explanation: Replaces an earlier record whose scope confused the review date with the source capture date. Content and source observation timestamps are unchanged. Reviewed against captured first-party passages by an assistant; this does not establish independent corroboration or a legal-register match. Review: Reviewed 2026-10-17T09:07:04.085Z; review due 2027-01-15T05:04:44.702Z. Published: 2026-10-17T09:07:04.085Z. Claim version: 1. Claim: [brandsource:arvinas:depth-chronology-2026-10-17:fact-4]() Sources: - [About Us \| Arvinas]() — Business statement; observed 2026-10-16T22:31:02.849Z; lineage: arvinas.com. ## Published overview Status: Withdrawn Value: No current supported value is available in this record. Scope: Published description of Arvinas on the cited official website, observed 2026-10-17. Explanation: Withdrawn because its scope mistakenly used the 2026-10-17 review date as the source observation date. The cited sources were captured on 2026-10-16; their original timestamps are preserved. The unchanged supported value is replaced by brandsource:arvinas:depth-chronology-2026-10-17:summary. Review: Reviewed 2026-10-17T09:07:04.085Z; review due 2027-01-15T05:04:44.702Z. Published: 2026-10-17T09:07:04.085Z. Claim version: 2. Claim: [brandsource:arvinas:depth-2026-10-17:summary]() Sources: - [About Us \| Arvinas]() — Business statement; observed 2026-10-16T22:31:02.849Z; lineage: arvinas.com. - [PROTAC Discovery Engine \| Arvinas]() — Business statement; observed 2026-10-16T22:31:03.357Z; lineage: arvinas.com. ## Published overview Status: Published by the business Value: Arvinas develops medicines based on targeted protein degradation, with research across oncology and neurology. Its PROTAC platform is designed to use the body’s protein-disposal system to degrade and remove disease-causing proteins. Scope: Published description of Arvinas on the cited official website; observation dates are recorded with each source. Explanation: Replaces an earlier record whose scope confused the review date with the source capture date. Content and source observation timestamps are unchanged. Reviewed against captured first-party passages by an assistant; this does not establish independent corroboration or a legal-register match. Review: Reviewed 2026-10-17T09:07:04.085Z; review due 2027-01-15T05:04:44.702Z. Published: 2026-10-17T09:07:04.085Z. Claim version: 1. Claim: [brandsource:arvinas:depth-chronology-2026-10-17:summary]() Sources: - [About Us \| Arvinas]() — Business statement; observed 2026-10-16T22:31:02.849Z; lineage: arvinas.com. - [PROTAC Discovery Engine \| Arvinas]() — Business statement; observed 2026-10-16T22:31:03.357Z; lineage: arvinas.com. ## Research areas Status: Withdrawn Value: No current supported value is available in this record. Scope: Published description of Arvinas on the cited official website, observed 2026-10-17. Explanation: Withdrawn because its scope mistakenly used the 2026-10-17 review date as the source observation date. The cited sources were captured on 2026-10-16; their original timestamps are preserved. The unchanged supported value is replaced by brandsource:arvinas:depth-chronology-2026-10-17:fact-3. Review: Reviewed 2026-10-17T09:07:04.085Z; review due 2027-01-15T05:04:44.702Z. Published: 2026-10-17T09:07:04.085Z. Claim version: 2. Claim: [brandsource:arvinas:depth-2026-10-17:fact-3]() Sources: - [PROTAC Discovery Engine \| Arvinas]() — Business statement; observed 2026-10-16T22:31:03.357Z; lineage: arvinas.com. ## Research areas Status: Published by the business Value: Oncology and neurology Scope: Published description of Arvinas on the cited official website; observation dates are recorded with each source. Explanation: Replaces an earlier record whose scope confused the review date with the source capture date. Content and source observation timestamps are unchanged. Reviewed against captured first-party passages by an assistant; this does not establish independent corroboration or a legal-register match. Review: Reviewed 2026-10-17T09:07:04.085Z; review due 2027-01-15T05:04:44.702Z. Published: 2026-10-17T09:07:04.085Z. Claim version: 1. Claim: [brandsource:arvinas:depth-chronology-2026-10-17:fact-3]() Sources: - [PROTAC Discovery Engine \| Arvinas]() — Business statement; observed 2026-10-16T22:31:03.357Z; lineage: arvinas.com. ## Unknowns and limits - PROTAC terminology: Withdrawn. - Published overview: Withdrawn. - Research areas: Withdrawn. - This brief does not establish answers to topics outside the listed claims.